Detalles de la búsqueda
1.
Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome.
Blood
; 134(16): 1346-1350, 2019 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31467061
2.
Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy.
Blood
; 125(1): 71-81, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25336628
3.
The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma.
J Am Acad Dermatol
; 84(1): 185-187, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32334059
4.
Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.
Leuk Lymphoma
; 62(2): 330-336, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33026266
5.
The efficacy of methotrexate for lymphomatoid papulosis.
J Am Acad Dermatol
; 72(6): 1088-90, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25981010
6.
Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides.
Cancers (Basel)
; 11(11)2019 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31717353
7.
Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data.
Eur J Cancer
; 156 Suppl 1: S18, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649645
Resultados
1 -
7
de 7
1
Próxima >
>>